Taro Pharmaceutical Industries Ltd. (TARO)

TARO Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Year Ending	Current	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	1,615	1,591	914	1,626	2,822	2,359
Market Cap Growth	74.10%	74.10%	-43.78%	-42.37%	19.63%	-44.66%
Enterprise Value	736	712	64	805	1,798	1,250
PE Ratio	30.05	29.54	35.92	27.91	-7.30	9.66
PS Ratio	2.57	2.53	1.60	2.90	5.14	3.66
PB Ratio	0.90	0.89	0.53	0.95	1.66	1.12
P/FCF Ratio	22.88	22.55	64.39	-9.54	98.05	9.63
P/OCF Ratio	12.97	12.78	28.79	-10.25	61.65	8.68
EV/Sales Ratio	1.17	1.13	0.11	1.43	3.28	1.94
EV/EBITDA Ratio	6.47	6.26	0.91	8.60	-4.82	4.62
EV/EBIT Ratio	8.90	8.61	1.67	11.90	-4.53	5.02
EV/FCF Ratio	10.42	10.09	4.50	-4.72	62.48	5.10
Quick Ratio	3.04	3.04	2.88	2.61	1.91	6.19
Current Ratio	3.61	3.61	3.47	3.10	2.17	6.88
Asset Turnover	0.29	0.29	0.27	0.25	0.23	0.28
Return on Equity (ROE)	3.10%	3.10%	1.50%	3.50%	-22.70%	12.00%
Return on Assets (ROA)	2.50%	2.50%	1.20%	2.60%	-16.20%	10.80%
Return on Capital (ROIC)	0.78%	0.78%	0.68%	2.96%	-24.12%	9.73%
Earnings Yield	3.34%	3.38%	2.78%	3.58%	-13.70%	10.35%
FCF Yield	4.37%	4.44%	1.55%	-10.49%	1.02%	10.39%
Buyback Yield / Dilution	-	0.15%	1.49%	0.65%	1.36%
Total Shareholder Return	-	0.15%	1.49%	0.65%	1.36%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).